This study introduces novel concepts and approaches for the clinical management of RA, providing a mechanistic framework in which exosomes derived from RA synoviocytes transfer circ-CBLB to macrophages, where it binds to TLR3 and inhibits TRAF3 signaling, thereby reducing M1 polarization. The gene discussed is CBLB; the disease is rheumatoid arthritis.